Notice: This company has been marked as potentially delisted and may not be actively trading. Ocuphire Pharma (OCUP) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Ocuphire Pharma Short Interest DataOcuphire Pharma (OCUP) has a short interest of 930,600 shares. This marks a -15.40% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.4, indicating that it would take 6.4 days of the average trading volume of 171,840 shares to cover all short positions.Current Short Interest930,600 sharesPrevious Short Interest1,100,000 sharesChange Vs. Previous Month-15.40%Dollar Volume Sold Short$1.22 millionShort Interest Ratio6.4 Days to CoverLast Record DateSeptember 30, 2024Outstanding Shares25,924,000 sharesPercentage of Shares Shorted3.59%Today's Trading Volume676,700 sharesAverage Trading Volume171,840 sharesToday's Volume Vs. Average394% Short Selling Ocuphire Pharma? Sign up to receive the latest short interest report for Ocuphire Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOCUP Short Interest Over TimeOCUP Days to Cover Over TimeOCUP Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Ocuphire Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/2024930,600 shares $1.22 million -15.4%N/A6.4 $1.31 9/15/20241,100,000 shares $1.43 million +6.8%N/A7.4 $1.30 8/31/20241,030,000 shares $1.28 million +3.7%N/A6.8 $1.24 8/15/2024993,700 shares $1.23 million +1.7%N/A6.5 $1.24 7/31/2024976,700 shares $1.94 million -16.5%N/A7.3 $1.99 7/15/20241,170,000 shares $2.41 million -15.8%N/A7.8 $2.06 Get the Latest News and Ratings for OCUP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ocuphire Pharma and its competitors with MarketBeat's FREE daily newsletter. 6/30/20241,390,000 shares $2.13 million +14.9%N/A9.2 $1.53 6/15/20241,210,000 shares $2.00 million -3.2%N/A6.5 $1.65 5/31/20241,250,000 shares $2.10 million -5.3%N/A6.2 $1.68 5/15/20241,320,000 shares $2.28 million +8.2%N/A6 $1.73 4/30/20241,220,000 shares $1.93 million -22.8%N/A5.3 $1.59 4/15/20241,580,000 shares $2.78 million +0.6%N/A7.1 $1.76 3/31/20241,570,000 shares $3.16 million -4.9%N/A7.1 $2.01 3/15/20241,650,000 shares $3.14 million -2.4%N/A7.8 $1.90 2/29/20241,690,000 shares $4.29 million -3.4%N/A7.9 $2.54 2/15/20241,750,000 shares $4.64 million +1.2%N/A8.1 $2.65 1/31/20241,730,000 shares $4.53 million +4.2%N/A7.6 $2.62 1/15/20241,660,000 shares $4.98 million +5.1%N/A7.6 $3.00 12/31/20231,580,000 shares $4.76 million -9.7%N/A7.3 $3.01 12/15/20231,750,000 shares $4.60 million -0.6%N/A6.2 $2.63 11/30/20231,760,000 shares $5.37 million +3.5%N/A6.4 $3.05 11/15/20231,700,000 shares $5.36 million -2.3%N/A6.5 $3.15 10/31/20231,740,000 shares $4.96 million -7.5%N/A7.1 $2.85 10/15/20231,880,000 shares $6.28 million +3.9%N/A8.2 $3.34 9/30/20231,810,000 shares $6.06 million +27.5%N/A8.1 $3.35 9/15/20231,420,000 shares $5.69 million -2.7%N/A8.2 $4.01 8/31/20231,460,000 shares $5.83 million -8.2%N/A10.2 $3.99 8/15/20231,590,000 shares $6.66 million -1.2%N/A9.5 $4.19 7/31/20231,610,000 shares $6.97 million -1.2%N/A6.8 $4.33 7/15/20231,630,000 shares $6.75 million +5.2%N/A5.1 $4.14 6/30/20231,550,000 shares $6.73 million +5.4%N/A4.2 $4.34 6/15/20231,470,000 shares $5.87 million -4.6%N/A3.8 $3.99 5/31/20231,540,000 shares $5.94 million -24.5%N/A4.1 $3.86 5/15/20232,040,000 shares $10.24 million +11.5%N/A6 $5.02 4/30/20231,830,000 shares $9.39 million +45.2%N/A6.9 $5.13 4/15/20231,260,000 shares $6.75 million +86.7%N/A5.2 $5.36 3/31/2023675,000 shares $2.53 million -25.5%N/A4.2 $3.75 3/15/2023906,400 shares $3.40 million +0.2%N/A7.2 $3.75 2/28/2023904,800 shares $3.12 million -3.4%N/A7 $3.45 2/15/2023936,500 shares $3.59 million -5.8%N/A6.8 $3.83Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad)Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. 1/31/2023994,000 shares $3.45 million -7.1%N/A3.7 $3.47 1/15/20231,070,000 shares $3.94 million +5.9%N/A4.4 $3.68 12/30/20221,010,000 shares $3.57 million -3.8%N/A4.3 $3.53 12/15/20221,050,000 shares $3.10 million -1.9%N/A5 $2.95 11/30/20221,070,000 shares $3.30 million -5.3%N/A5.2 $3.08 11/15/20221,130,000 shares $3.22 million +220.3%N/A5.7 $2.85 10/31/2022352,800 shares $829,080.00 +16.5%N/A2 $2.35 10/15/2022302,800 shares $663,132.00 -25.1%N/A3.9 $2.19 9/30/2022404,300 shares $812,643.00 -12.0%N/A5.3 $2.01 9/15/2022459,400 shares $1.06 million -0.4%N/A5.4 $2.30 8/31/2022461,400 shares $1.05 million -16.9%N/A5.1 $2.27 8/15/2022555,500 shares $1.40 million +104.9%N/A5.6 $2.52 7/31/2022271,100 shares $506,957.00 +4.6%N/A2.5 $1.87 7/15/2022259,200 shares $495,072.00 -4.4%N/A2.3 $1.91 6/30/2022271,200 shares $520,704.00 -11.6%N/A2.1 $1.92 6/15/2022306,800 shares $564,512.00 -22.7%N/A1.6 $1.84 5/31/2022397,100 shares $841,852.00 +28.8%N/A1.9 $2.12 5/15/2022308,300 shares $662,845.00 +3.4%N/A1.5 $2.15 4/30/2022298,200 shares $697,788.00 -1.3%N/A1.6 $2.34 4/15/2022302,100 shares $845,880.00 +2.9%N/A1.5 $2.80 3/31/2022293,600 shares $951,264.00 +77.0%N/A1.4 $3.24 3/15/2022165,900 shares $552,447.00 +18.5%N/A0.9 $3.33 2/28/2022140,000 shares $478,800.00 -2.5%N/A0.6 $3.42 2/15/2022143,600 shares $488,240.00 -18.3%N/A0.1 $3.40 1/31/2022175,800 shares $557,286.00 -35.8%N/A0.1 $3.17 1/15/2022273,700 shares $1.01 million -44.8%N/A0.2 $3.69 12/31/2021495,700 shares $1.85 million -42.9%N/A0.3 $3.73 12/15/2021868,600 shares $3.33 million -64.7%N/A0.5 $3.83 11/30/20212,460,000 shares $9.62 million +550.6%N/A1.4 $3.91 11/15/2021378,100 shares $1.49 million -15.1%N/A0.2 $3.95 10/29/2021445,400 shares $1.75 million -27.0%N/A2.1 $3.94 10/15/2021610,200 shares $2.62 million -19.7%N/A2 $4.29 9/30/2021760,200 shares $3.92 million +29.9%N/A2.2 $5.15 9/15/2021585,300 shares $2.87 million -29.4%N/A0.4 $4.91 8/31/2021828,500 shares $3.69 million -31.0%N/A0.6 $4.45 8/13/20211,200,000 shares $5.46 million -23.6%N/A0.8 $4.55 7/30/20211,570,000 shares $6.59 million -17.4%N/A1 $4.20 7/15/20211,900,000 shares $7.54 million +311.3%N/A1.3 $3.97 6/30/2021461,900 shares $2.44 million -20.2%N/A0.3 $5.28 6/15/2021578,600 shares $3.04 million +8.9%5.6%1.2 $5.25 5/28/2021531,100 shares $2.41 million -12.0%4.9%1 $4.54 5/14/2021603,600 shares $2.67 million -2.5%5.7%1.3 $4.43 4/30/2021619,000 shares $3.16 million +85.8%5.9%1.5 $5.11 4/15/2021333,200 shares $1.64 million +118.8%3.6%0.9 $4.91 3/31/2021152,300 shares $868,110.00 +2,045.1%1.7%0.4 $5.70 3/15/20217,100 shares $56,445.00 -60.6%0.1%0 $7.95 2/26/202118,000 shares $191,520.00 +125.0%0.2%0.2 $10.64 2/12/20218,000 shares $97,040.00 -67.6%0.1%0.1 $12.13 1/29/202124,700 shares $295,041.50 +107.6%0.2%0.3 $11.95 1/15/202111,900 shares $82,824.00 No Change0.1%0.2 $6.96Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad)Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. OCUP Short Interest - Frequently Asked Questions What is Ocuphire Pharma's current short interest? Short interest is the volume of Ocuphire Pharma shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 930,600 shares of OCUP short. Learn More on Ocuphire Pharma's current short interest. What is a good short interest ratio for Ocuphire Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OCUP shares currently have a short interest ratio of 6.0. Learn More on Ocuphire Pharma's short interest ratio. Is Ocuphire Pharma's short interest increasing or decreasing? Ocuphire Pharma saw a drop in short interest in the month of September. As of September 30th, there was short interest totaling 930,600 shares, a drop of 15.4% from the previous total of 1,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ocuphire Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ocuphire Pharma: Leap Therapeutics, Inc. (4.97%), Veru Inc. (8.68%), Regulus Therapeutics Inc. (2.65%), Journey Medical Co. (0.76%), Alto Neuroscience, Inc. (18.59%), Immunic, Inc. (4.65%), Skye Bioscience, Inc. (9.05%), MediciNova, Inc. (0.72%), Context Therapeutics Inc. (1.36%), Avalo Therapeutics, Inc. (0.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks. What does it mean to sell short Ocuphire Pharma stock? Short selling OCUP is an investing strategy that aims to generate trading profit from Ocuphire Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ocuphire Pharma? A short squeeze for Ocuphire Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OCUP, which in turn drives the price of the stock up even further. How often is Ocuphire Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OCUP, twice per month. The most recent reporting period available is September, 30 2024. More Short Interest Resources from MarketBeat Related Companies LPTX Short Squeeze VERU Short Squeeze RGLS Short Squeeze DERM Short Squeeze ANRO Short Squeeze IMUX Short Squeeze SKYE Short Squeeze MNOV Short Squeeze CNTX Short Squeeze AVTX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OCUP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocuphire Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocuphire Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
